The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The physical basis of how prion conformations determine strain phenotypes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
[URE3] as an Altered URE2 Protein: Evidence for a Prion Analog in Saccharomyces cerevisiae
Wickner, R. B. (1994) · Science · doi:10.1126/science.7909170 · Cited by 1,209
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021
The most infectious prion protein particles
Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., & Caughey, B. (2005) · Nature · doi:10.1038/nature03989 · Cited by 899
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790
Conformational variations in an infectious protein determine prion strain differences
Tanaka, M., Chien, P., Naber, N., Cooke, R., & Weissman, J. S. (2004) · Nature · doi:10.1038/nature02392 · Cited by 770
Self-citationPrions as adaptive conduits of memory and inheritance
Shorter, J., & Lindquist, S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1616 · Cited by 555
Genesis and Variability of [PSI] Prion Factors in Saccharomyces cerevisiae
Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G., & Liebman, S. W. (1996) · Genetics · doi:10.1093/genetics/144.4.1375 · Cited by 524
Cited by
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
“Paired betasheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy.”
BackgroundAtomic structures of amyloid cross-β spines reveal varied steric zippers
Sawaya, M. R., Sambashivan, S., Nelson, R., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J. W., McFarlane, H. T., et al. (2007) · Nature · doi:10.1038/nature05695 · Cited by 2,271
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Paravastu, A. K., Leapman, R. D., Yau, W.-M., & Tycko, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806270105 · Cited by 1,160
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Knowles, T. P. J., Waudby, C. A., Devlin, G. L., Cohen, S. I. A., Aguzzi, A., Vendruscolo, M., Terentjev, E. M., Welland, M. E., & Dobson, C. M. (2009) · Science · doi:10.1126/science.1178250 · Cited by 1,139
Fuzzy complexes: polymorphism and structural disorder in protein–protein interactions
Tompa, P., & Fuxreiter, M. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.10.003 · Cited by 1,086
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986
Goedert, M. (2015) · Science · doi:10.1126/science.1255555 · Cited by 976
A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins
Alberti, S., Halfmann, R., King, O., Kapila, A., & Lindquist, S. (2009) · Cell · doi:10.1016/j.cell.2009.02.044 · Cited by 968
Structural and functional characterization of two alpha-synuclein strains
Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Olieric, V., Böckmann, A., Meier, B. H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3575 · Cited by 909
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Wei, G., Su, Z., Reynolds, N. P., Arosio, P., Hamley, I. W., Gazit, E., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00542j · Cited by 904
Nanomechanics of functional and pathological amyloid materials
Knowles, T. P. J., & Buehler, M. J. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.102 · Cited by 784
Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils
Knowles, T. P., Fitzpatrick, A. W., Meehan, S., Mott, H. R., Vendruscolo, M., Dobson, C. M., & Welland, M. E. (2007) · Science · doi:10.1126/science.1150057 · Cited by 782
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Characterization of the nanoscale properties of individual amyloid fibrils
Smith, J. F., Knowles, T. P. J., Dobson, C. M., MacPhee, C. E., & Welland, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604035103 · Cited by 640
Amyloid Fibrils as Building Blocks for Natural and Artificial Functional Materials
Knowles, T. P. J., & Mezzenga, R. (2016) · Advanced Materials · doi:10.1002/adma.201505961 · Cited by 586
Prions: Protein Aggregation and Infectious Diseases
Aguzzi, A., & Calella, A. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00006.2009 · Cited by 504
Cellular Strategies of Protein Quality Control
Chen, B., Retzlaff, M., Roos, T., & Frydman, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004374 · Cited by 502
Xue, W.-F., Homans, S. W., & Radford, S. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711664105 · Cited by 476
From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
Cohen, S. I. A., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.02.031 · Cited by 475
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450
Folding versus aggregation: Polypeptide conformations on competing pathways
Jahn, T. R., & Radford, S. E. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.05.015 · Cited by 428
Molecular Mechanisms of Amyloid Oligomers Toxicity
Kayed, R., & Lasagna-Reeves, C. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129001 · Cited by 415
Fibril Fragmentation Enhances Amyloid Cytotoxicity
Xue, W.-F., Hellewell, A. L., Gosal, W. S., Homans, S. W., Hewitt, E. W., & Radford, S. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049809 · Cited by 384
Polymorphism in the intermediates and products of amyloid assembly
Kodali, R., & Wetzel, R. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.01.007 · Cited by 376
Liebman, S. W., & Chernoff, Y. O. (2012) · Genetics · doi:10.1534/genetics.111.137760 · Cited by 372
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
Cohen, S. I. A., Vendruscolo, M., Welland, M. E., Dobson, C. M., Terentjev, E. M., & Knowles, T. P. J. (2011) · The Journal of Chemical Physics · doi:10.1063/1.3608916 · Cited by 362
Neurodegenerative Diseases: Expanding the Prion Concept
Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361
“Notably, the potential to form conformationally distinct proteinaceous strains is now considered a generic property of amyloid-forming proteins (Chiti & Dobson 2006, Eisenberg & Jucker 2012, Knowles et al. 2014, Tanaka et al. 2006).”
BackgroundThe structural basis of yeast prion strain variants
Toyama, B. H., Kelly, M. J. S., Gross, J. D., & Weissman, J. S. (2007) · Nature · doi:10.1038/nature06108 · Cited by 338
Self-citationGetting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Caughey, B., Baron, G. S., Chesebro, B., & Jeffrey, M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145410 · Cited by 323
Propagation of Protein Aggregation in Neurodegenerative Diseases
Vaquer-Alicea, J., & Diamond, M. I. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045049 · Cited by 310
Amyloid Structure: Conformational Diversity and Consequences
Toyama, B. H., & Weissman, J. S. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-090908-120656 · Cited by 304
Self-citationPrion-like disorders: blurring the divide between transmissibility and infectivity
Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., & Shorter, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.051672 · Cited by 289
Arosio, P., Michaels, T. C. T., Linse, S., Månsson, C., Emanuelsson, C., Presto, J., Johansson, J., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2016) · Nature Communications · doi:10.1038/ncomms10948 · Cited by 265
Molecular mechanisms for protein-encoded inheritance
Wiltzius, J. J. W., Landau, M., Nelson, R., Sawaya, M. R., Apostol, M. I., Goldschmidt, L., Soriaga, A. B., Cascio, D., Rajashankar, K., & Eisenberg, D. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1643 · Cited by 259
Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates
Falcon, B., Cavallini, A., Angers, R., Glover, S., Murray, T. K., Barnham, L., Jackson, S., O'Neill, M. J., Isaacs, A. M., Hutton, M. L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589309 · Cited by 254
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change
Frost, B., Ollesch, J., Wille, H., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805627200 · Cited by 224
Pathogenesis of prion diseases: current status and future outlook
Aguzzi, A., & Heikenwalder, M. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1492 · Cited by 207
The prion hypothesis: from biological anomaly to basic regulatory mechanism
Tuite, M. F., & Serio, T. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3007 · Cited by 146
Fibril fragmentation in amyloid assembly and cytotoxicity: When size matters
Xue, W.-F., Hellewell, A. L., Hewitt, E. W., & Radford, S. E. (2010) · Prion · doi:10.4161/pri.4.1.11378 · Cited by 117
“Different oligomeric species that accumulate during the early stages of fibril assembly have been suggested as the origin of the cytotoxicity associated with amyloid disease, and fibril fragmentation that shortens fibril length and increases the number of fibrils is a key secondary process that accelerates amyloid ass…”
BackgroundAlphaFold and the amyloid landscape
Pinheiro, F., Santos, J., & Ventura, S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167059 · Cited by 88
Long, H., Zheng, W., Liu, Y., Sun, Y., Zhao, K., Liu, Z., Xia, W., Lv, S., Liu, Z., Li, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012435118 · Cited by 60
Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease
Kim, C., Haldiman, T., Kang, S.-G., Hromadkova, L., Han, Z. Z., Chen, W., Lissemore, F., Lerner, A., de Silva, R., Cohen, M. L., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg0253 · Cited by 55
“Prior studies on yeast and rodent-adapted prions posit that lower stability of prion oligomers correlates with easier fragmentation, which is presumably responsible for faster replication and more rapid progression of disease (80, 81).”
BackgroundBeal, D. M., Tournus, M., Marchante, R., Purton, T. J., Smith, D. P., Tuite, M. F., Doumic, M., & Xue, W.-F. (2020) · iScience · doi:10.1016/j.isci.2020.101512 · Cited by 29
Direct Demonstration of Seed Size-Dependent α-Synuclein Amyloid Amplification
Sakunthala, A., Datta, D., Navalkar, A., Gadhe, L., Kadu, P., Patel, K., Mehra, S., Kumar, R., Chatterjee, D., Devi, J., et al. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c01650 · Cited by 16
Metadata
- Authors
- Tanaka, M., Collins, S. R., Toyama, B. H., & Weissman, J. S.
- Venue
- Nature
- Published
- 2006-06-28
- Volume
- 442
- Issue
- 7102
- Pages
- 585-589
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1978959047
- Cited by
- 593
- References
- 29
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.